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SUMMARY
Thorough studies on whether point prevalence surveys of healthcare-associated infections (HAIs)
can be used to reliably estimate incidence of surgical site infections (SSIs) are scarce. We
examined this topic using surveillance data of 58 hospitals that participated in two Dutch
national surveillances; HAI prevalence and SSI incidence surveillance, respectively. First, we
simulated daily prevalences of SSIs from incidence data. Subsequently, Rhame & Sudderth’s
formula was used to estimate SSI incidence from prevalence. Finally, we developed random-
effects models to predict SSI incidence from prevalence and other relevant variables. The
prevalences simulated from incidence data indicated that daily prevalence varied greatly.
Incidences calculated with Rhame & Sudderth’s formula often had values below zero, due to
the large number of SSIs occurring post-discharge. Excluding these SSIs, still resulted in poor
correlation between calculated and observed incidence. The two models best predicting total
incidence and incidence during initial hospital stay both performed poorly (proportion of
explained variance of 0·25 and 0·10, respectively). In conclusion, incidence of SSIs cannot be
reliably estimated from point prevalence data in Dutch hospitals by any of the applied methods.
We therefore conclude that prevalence surveys are not a useful measure to give reliable insight
into incidence of SSIs.
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INTRODUCTION
A surgical site infection (SSI) is a severe surgical com-
plication and is among the most frequently reported
types of healthcare associated infections (HAIs) [1].
SSIs are associated with increased morbidity and mor-
tality, as well as a prolonged hospital stay and a high
number of hospital readmissions [2–4]. Active surveil-
lance has proved to be an effective tool in infection
control programmes [5–9], although the risk reduction
attributed to surveillance varies [8, 10, 11]. The gold
standard for SSI surveillance is prospective incidence
surveillance [12, 13], which gives accurate and detailed
information on the occurrence of new cases within a
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standardized follow-up period. However, in order to
provide reliable estimates it typically requires pro-
longed data collection. Recently, an increasing number
of countries as well as the American and European
Centers for Disease Control and Prevention (CDC
and ECDC) have started to include prevalence surveys
in their HAI surveillance programmes [14, 15].
Prevalence surveys measure the proportion of infec-
tions at one point in time (or over a short period) in
all patients hospitalized at that time. Prevalence surveys
are attractive because they are less labour-intensive and
cheaper compared to incidence surveillance. On the
other hand, prevalence surveys are less speciﬁc since
they usually include all types of HAI. When performed
regularly, however, they can be used to visualize trends
in the occurrence of infections or to evaluate infection
control programmes [16]. Despite the different objec-
tives of the two surveillance methods, several studies
have attempted to convert HAI prevalence into inci-
dence. For this purpose, some formulas have been
developed [17–19], which are based on the relationship
between incidence and prevalence via the estimated
duration of the infection. The most frequently used for-
mula is that of Rhame & Sudderth [13, 20–23], which,
however, has not been extensively applied nor studied
for calculating incidence of SSIs [15, 21, 24].
In the Dutch national surveillance network on
nosocomial infections (PREZIES), SSI incidence sur-
veillance as well as biannual point prevalence surveys
of all HAIs are carried out. Recently, it was proposed
to use the results from the prevalence surveys to esti-
mate SSI incidence, in order to substantially reduce
the national burden of HAI surveillance. As available
evidence regarding the use of prevalence surveys for
this purpose was insufﬁcient in The Netherlands, in
the present study we aim to investigate whether SSI
incidence can be reliably predicted from SSI preva-
lence data reported by Dutch hospitals.
METHODS
SSI incidence surveillance
The SSI incidence surveillance of PREZIES is an
ongoing programme in which hospitals participate
voluntarily. Information concerning patient and oper-
ation characteristics, risk factors for SSIs and the
occurrence of an SSI are collected. The deﬁnitions
used to diagnose SSIs are based on the deﬁnitions of
ECDC and CDC [25–27]. As a large proportion of
SSIs develop after discharge from the hospital, post-
discharge surveillance is necessary to detect these
infections. A more detailed description of the inci-
dence surveillance has been published previously [8,
28, 29].
HAI prevalence surveys
PREZIES HAI prevalence surveys are performed
twice a year, in March and October. All inpatients
admitted to the hospital before the day of the survey
and aged 51 year are included. The collected data
include patient characteristics as well as risk factors
for HAIs and the presence of any type of HAI. The
deﬁnitions used to diagnose SSIs related to the current
hospital stay are the same as those used in the incidence
surveillance. For SSIs present at admission (and there-
fore related to a previous hospitalization) diagnosis is
based on patient history (instead of based on surveil-
lance deﬁnitions) and infections are reported also
when they are already cured at the day of the survey.
The methods used in the HAI prevalence survey have
been described in detail elsewhere [30].
Data selection
We included data from hospitals participating simul-
taneously in both surveillance programmes in the
years 2007–2011, linking cumulative SSI incidence to
the prevalence in each hospital per year. Specialities
with fewer than 20 surgeries in either surveillance pro-
gramme were excluded. No outbreaks of SSIs were
reported by the hospitals during the study period.
Cumulative incidence was calculated by dividing the
number of operations resulting in an SSI by the total
number of operations performed per surveillance year.
Prevalence of SSIs was calculated as the number of
SSIs (active or under treatment and related to the cur-
rent hospital stay) at the time of the survey, divided by
the total number of surgical patients in the hospital at
the time of the survey. When hospitals participated in
two prevalence surveys in the same year, combined
prevalence was calculated using the total number of
surgical patients hospitalized during both surveys.
SSIs present at admission were excluded in the preva-
lence surveys, as diagnosis is not based on surveillance
deﬁnitions and because these patients did not neces-
sarily underwent surgery during their readmission
and may therefore not be included in the denominator
(total number of surgical patients in the hospital).
For our analyses, we produced three datasets aggre-
gated at hospital level. The ﬁrst, dataset I, included
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incidence based on all reported SSIs. Dataset II
included incidence based on SSIs diagnosed during
the initial hospital stay only. Finally, dataset III was
based on prevalence data and included only SSIs diag-
nosed during the initial hospital stay.
Data analysis
First, we assessed the variability of daily point preva-
lence rates within 1 month. For this purpose, daily
prevalence of SSIs was simulated from incidence
data for each day of the month in which the preva-
lence survey might be performed. Only SSIs detected
during the initial hospital stay were included (dataset
II). Daily prevalence was calculated both at the hos-
pital and the national level.
Second, we used the formula of Rhame & Sudderth
to estimate annual SSI incidence from prevalence
(dataset III) [17]. The relationship between incidence
(I) and prevalence (P) in this method is
I = P × LA
LN− INT .
Applied to our study, LA represents the mean length
of hospitalization of all patients, LN is the mean
length of hospitalization of patients who acquire an
SSI, and INT is the mean interval between hospital
admission and onset of the SSI.
Since these values could not be derived from the
prevalence surveys, they were calculated based on
the incidence surveillance. We included, for each hos-
pital, only the specialities that were registered in both
surveillance programmes. The values were then calcu-
lated taking into account the distribution of patients
over the different specialities in the prevalence survey.
The accuracy of Rhame & Sudderth’s formula was
evaluated by comparing the estimated incidence to
the observed incidence. The analysis was performed
twice, ﬁrst using incidence based on all SSIs (dataset
I) and thereafter including only SSIs detected during
initial hospital stay (dataset II).
In the third part of our analyses we developed a lin-
ear model to predict SSI incidence from prevalence
and other relevant variables including LA, LN,
INT, LN minus INT, hospital type, gender, median
age and wound class. Because of assumed differences
in infection risk between hospitals, hospitals were
assigned a random effect. The model was ﬁtted
twice, using both incidence of all SSIs (dataset I)
and of SSIs detected during initial hospital stay only
(dataset II). Because the relationship between
incidence and the predictor variables was more likely
to be multiplicative than additive, the prediction mod-
els adopted were linear on log-transformed variables,
but the predictions of the log-incidence were trans-
formed back to yield predictions of incidence ‘on the
normal scale’. The predictive performance of the
models was assessed by leave-one-out cross-validation
[31]. We quantiﬁed the performance of the models by
the model’s proportion of explained variance and by
looking at the distribution of the percent difference
between the predicted and observed incidence:
Percent difference= predicted− observed
observed
× 100%.
The analyses of the incidence prediction models
were performed with R statistical software v. 3.0.1
(R Foundation, Austria). All other analyses were per-
formed with SAS v. 9.3 (SAS Institute Inc., USA).
RESULTS
Fifty-eight hospitals that participated in both surveil-
lance programmes for 1–5 years were matched.
Figure 1 shows the ﬂowchart of the data inclusion pro-
cess. Of the 90 337 included surgeries from the inci-
dence surveillance (ranging from 4613 in 2007 to
37 246 in 2011) 2502 SSIs were observed, of which
838 (33%) were diagnosed during initial hospitaliza-
tion. We included 13 288 surgical patients from the
prevalence surveys (ranging from 721 in 2007 to
4258 in 2011) of which 517 had an SSI related to
the current hospital stay at time of the survey.
Table 1 presents the number of surgical patients,
SSIs, lengths of stay and patient characteristics per
speciality. The results are presented separately for
the dataset including all SSIs (dataset I) and the data-
set including SSIs diagnosed during the initial hospital
stay only (dataset II). The length of stay of the total
patient population (LA) is the same in both datasets,
but in dataset II the value of LN is higher and the
value of INT fell, as a result of the selection of SSIs
during admission only.
Prevalence simulations
Daily prevalence simulated from incidence surveil-
lance dataset II showed substantial variation during
the month, both at hospital and national levels
(Fig. 2). As expected, the daily variation in prevalence
was larger for individual hospitals. Estimates from
SSI incidence derived from prevalence surveys 3
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other hospitals and national survey months yielded
results comparable to the ones presented.
Rhame & Sudderth method
Estimates of SSI incidence according to the Rhame &
Sudderth method were in most cases lower than the
incidence surveillance observations based on all
reported SSIs (dataset I), and only ﬁve (6·1%) out of
82 estimates fell within the 95% conﬁdence interval
(CI) for the observed incidence (Fig. 3). The
Spearman correlation coefﬁcient between estimated
and observed incidence was 0·22, indicating a very
weak association. The results presented in Figure 4
are analogous to those of Figure 3 but are based on
only those SSIs diagnosed during initial hospital stay
(dataset II). Out of 70 estimates, 29 (41%) fell within
the 95% CI for the observed incidence. The
Spearman correlation coefﬁcient between estimated
and observed incidence was 0·35.
Incidence prediction model
Figures 5 and 6 show the results of the models best
predicting total SSI incidence (dataset I) and incidence
of SSIs during initial hospital stay (dataset II), respect-
ively. Variables included in the best performing
models were prevalence, LA, LN, gender and hospital
as random effect. The performance of the models was
quantiﬁed on the log scale with the proportion of
explained variance, which was 0·27 for total SSI inci-
dence and 0·24 for SSIs during initial hospital stay.
The mean percent difference in the model for inci-
dence of all SSIs was 12%, with a 95% prediction
interval ranging from –60% to 145%. For the model
on SSIs during initial hospital stay only, the mean per-
cent difference was 43%, with a 95% prediction inter-
val ranging from –85% to 405%.
DISCUSSION
This study showed that HAI prevalence survey data
from Dutch hospitals are not suitable to reliably esti-
mate SSI incidence, either by the existing model of
Rhame & Sudderth or by our newly developed predic-
tion model including several predictive factors. A ﬁrst
indication of the limitations of prevalence data to esti-
mate SSI incidence was given by the daily ﬂuctuations
in the simulated SSI prevalence within a 1-month
period. However, as these analyses were based on
data including only a subset of specialities, the vari-
ability of the true (unselected) SSI prevalence is prob-
ably smaller, as variability decreases with higher
numbers. Nevertheless, our results at the national
level indicate that daily prevalence ﬂuctuates substan-
tially even when the number of patients is large.
When we estimated SSI incidence from prevalence
with Rhame & Sudderth’s formula, correlation with
the observed SSI incidence was poor. Moreover, the
incidence estimations based on all SSIs greatly
Fig. 1. Flowchart of data inclusion. EG, Endocrine glands; ER, ears, nose and throat; EY, ophthalmology; UNK,
unknown speciality.
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Table 1. Number of surgical patients, SSIs and patient characteristics in the incidence surveillance and prevalence surveys, per speciality
Speciality
BL BR FGO GI HCV MGO MS NS OBS PV RS RU SS
Incidence surveillance
Surgical patients (N) 871 6264 2967 9900 1375 99 57 254 1376 9058 959 54 127 33
All SSIs
SSI, % (N) 2·8 (24) 3·7 (231) 1·1 (33) 8·5 (845) 4·1 (56) 1·0 (1) 1·8 (1055) 1·2 (17) 1·4 (125) 11·6 (111) 1·9 (1) 1·6 (2) 3·0 (1)
LA (days) 1·7 2·0 3·8 7·7 10·9 0·5 6·8 4·2 4·7 10·9 10·7 8·0 3·5
LN (days) 3·0 3·2 6·1 21·4 17·9 0·0 12·9 12·5 4·7 16·8 45·0 8·5 0·0
INT (days) 14·0 14·9 12·5 12·3 36·0 15·0 41·6 18·5 14·3 25·2 24·0 12·5 6·0
SSIs during hospital stay
SSI, % (N) 0·3 (3) 0·3 (16) 0·2 (6) 5·3 (526) 1·5 (21) 0·0 (0) 0·4 (216) 0·3 (4) 0·1 (7) 4·0 (38) 1·9 (1) 0·0 (0) 0·0 (0)
LA (days) 1·7 2·0 3·8 7·7 10·9 0·5 6·8 4·2 4·7 10·9 10·7 8·0 3·5
LN (days) 9·7 11·1 13·0 30·4 32·2 − 34·6 38·3 15·1 29·6 45·0 − −
INT (days) 3·0 6·4 5·7 11·0 13·8 − 13·6 19·5 7·6 15·1 24·0 − −
Patient characteristics
Gender (% men) 11·8 1·6 0·0 41·8 80·5 100·0 32·4 50·9 0·0 66·6 59·3 58·3 3·0
Age, median, years, IQR 58 (49–67) 59 (49–69) 48 (42–56) 60 (44–72) 72 (65–77) 24 (9–60) 71 (63–78) 64 (54–73) 31 (28–35) 72 (64–78) 64 (47–71) 66 (56–74) 51 (38–55)
Wound class (%)
<3 95·9 98·2 98·4 82·1 95·4 99·0 98·9 99·5 94·7 95·0 94·4 99·2 97·0
53 0·5 0·2 0·1 15·4 0·7 1·0 0·1 0·3 0·1 0·7 5·6 0·0 0·0
UNK 3·7 1·6 1·6 2·5 3·9 0·0 1·0 0·2 5·2 4·3 0·0 0·8 3·0
Prevalence survey
Surgical patients (N) 104 253 860 2853 1198 249 4731 494 492 387 462 702 503
SSI, % (N) 2·9 (3) 1·6 (4) 0·9 (8) 9·1 (261) 4·5 (54) 0·8 (2) 2·4 (115) 2·2 (11) 0·4 (2) 5·9 (23) 1·1 (5) 2·4 (17) 2·4 (12)
Patient characteristics
Gender (% men) 37·5 2·0 0 50·6 69·2 100 38·5 48·0 0 54·3 59·1 71·1 49·1
Age, median, years, IQR 60 (50–73) 56 (46–71) 48 (30–64) 65 (53–75) 70 (61–77) 69 (62–76) 71 (60–81) 60 (48–72) 32 (28–36) 70 (61–77) 59 (41–69) 69 (60–76) 65 (49–78)
Wound class (%)
<3 93·3 93·3 85·5 71·1 89·7 83·9 85·3 96·0 93·1 88·9 87·5 90·0 51·3
53 1·0 3·6 6·1 20·7 2·9 1·6 10·0 2·6 2·0 4·9 5·2 2·6 39·4
UNK 5·8 3·2 8·5 8·2 7·4 14·5 4·71 1·4 4·9 6·2 7·4 7·4 9·3
BL, Blood and lymphatic system; BR, Breast; FGO, Female genital organs; GI, Gastrointestinal system; HCV, Heart and central vascular system; MGO, Male genital
organs; MS, Musculoskeletal system; NS, Nervous system; OBS, Obstetrics; PV, Peripheral vascular system; RS, Respiratory system; RU, Renal and urinal system; SS,
Skin and subcutaneous tissue.
INT, mean interval between hospital admission and onset of the SSI; IQR, interquartile range; LA, mean length of hospitalization of all patients; LN, mean length of






























underestimated the incidence surveillance observa-
tions and were frequently smaller than zero. This
could partly be explained by the fact that from the
prevalence surveys we included only the SSIs that
occurred during the initial hospital stay, and therefore
underestimated the actual prevalence. However, in
addition, the incidence estimates smaller than zero
were caused by the assumption in the Rhame &
Sudderth method that all infections occur in the hos-
pital. The method hereby assumes that patients have
surgery and either stay in the hospital until they
develop an infection, or go home without complica-
tions. The term ‘LN-INT’ in the formula, which
describes the period in which patients are admitted
to the hospital with an infection, is then a proxy for
the duration of infection. However, when the majority
of SSIs occur post-discharge and therefore do not
inﬂuence the initial length of hospitalization, as was
the case in our study, this term becomes meaningless.
The Rhame & Sudderth method is therefore not
applicable to the present situation in Dutch hospitals.
When we applied the formula including only SSIs
occurring during initial hospitalization, a higher
percentage of estimated incidences fell within the
range of the incidence surveillance observations, but
the correlation between both was still poor. These
results conﬁrm our ﬁndings that the formula is not
adequate for estimating SSI incidence.
In the multilevel prediction models we could not
ﬁnd any combination of (risk) factors that reliably
predicted SSI incidence. A possible explanation for
the poor performance of the models is that incidence
at the hospital level depends heavily on the type and
number of reported specialities (as selected by the hos-
pital). For instance, a high-risk surgery (e.g. colec-
tomy) will increase the overall incidence, whereas a
low-risk surgery (e.g. total hip replacement) has a
reducing effect. Another explanation is that the
included risk factors are not associated with SSI to
the same extent in all specialities, for which reason
the impact of a factor on a speciality might be elimi-
nated by the lack of impact on another. Taking
these remarks into account, it might not be possible
to predict SSI incidence at the hospital level.
However, due to the small numbers of patients and
infections per speciality in the prevalence surveys, it
Fig. 2. Daily prevalence simulated from incidence dataset II (a) at a single hospital in March 2010 and (b) at national
level in October 2011.
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was not possible to extend the model to speciality- or
procedure-speciﬁc SSI incidence predictions.
A considerable number of studies have used the
Rhame & Sudderth method to calculate HAI inci-
dence from prevalence survey data [13, 20, 21, 23,
32–34], but only few have rigorously investigated the
applicability of the method for SSIs [21, 24]. In a
report on the 2007 Scottish national HAI prevalence
survey, SSI incidence was estimated per surgical
category [24]. Because of small numbers, only three
Fig. 3. Comparison of observed and estimated incidence of surgical site infections (SSIs) per year at hospital level, for all
reported SSIs (dataset I). Estimated incidence was calculated using the Rhame & Sudderth method. One extreme pair of
points (observed incidence 7·1%, estimated incidence 105·5%) is not displayed. The diagonal line represents the situation in
which the observed and estimated incidence are equal.
Fig. 4. Comparison of observed and estimated incidence of surgical site infections (SSIs) per year at hospital level, for
SSIs occurring during the initial hospital stay (dataset II). Estimated incidence was calculated using the Rhame &
Sudderth method. Two extreme pairs of points (observed incidence 0·5%, estimated incidence 32·7%; and observed
incidence 0·4%, estimated incidence 25·6%) are not displayed. The diagonal line represents the situation in which the
observed and estimated incidence are equal.
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categories had sufﬁcient data for comparison. The
results were highly variable and included no reliable
estimates; however, Gastmeier et al. did ﬁnd promis-
ing results [21]. For eight hospitals combined,
estimated SSI incidence and prevalence were within
the 95% CI of the corresponding observed rate.
However, their study differed from ours in several
aspects. First, their study was performed as part of
Fig. 5. (a) Comparison of observed and predicted surgical
site infection (SSI) incidence and (b) distribution of the
percental prediction error, illustrating the performance of
the prediction model best predicting SSI incidence (dataset
I). The diagonal line in (a) represents the situation in
which the observed and predicted incidence are equal. The
vertical dotted lines in (b) display the mean percental
prediction error (in bold) and its 95% prediction interval.
Fig. 6. (a) Comparison of observed and predicted surgical
site infection (SSI) incidence and (b) distribution of the
percental prediction error, illustrating the performance of
the prediction model best predicting incidence of SSIs
occurring during the initial hospital stay (dataset II). The
diagonal line in (a) represents the situation in which the
observed and predicted incidence are equal. The vertical
dotted lines in (b) display the mean percent prediction
error (in bold) and its 95% prediction interval.
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an infection control management study for all HAIs,
including three prevalence surveys and incidence sur-
veillance on all patients discharged during an 8-week
period. Second, only infections that developed during
hospital stay were reported, which does not adequately
reﬂect actual surveillance results. In addition, Gastmeier
et al. showed the incidence estimates for individual
HAI, including SSIs, only for all hospitals combined.
These results indicate that combining outcomes of
repeated prevalence surveys may reduce variability. A
study by Ustun et al. using the mean prevalence from
weekly surveys also demonstrated a close relationship
between prevalence and incidence [13]. If hospitals
had performed several (or at least more than two)
prevalence surveys per year, we might have found simi-
lar results. Our study, however, focused on estimating
SSI incidence from prevalence surveys in the current
ongoing nationwide programme, reﬂecting daily prac-
tice, rather than from multiple surveys that were part
of a single short-term study. To the best of our knowl-
edge there are no published alternative methods to cal-
culate or predict SSI incidence for data aggregated at
hospital level. Other prediction models for SSIs exist,
but these are aimed at predicting the risk for individual
patients [35–38].
This study has several important strengths. Data
were derived from a national surveillance network
that uses a standardized protocol with strict deﬁni-
tions to diagnose SSIs and mandatory onsite valid-
ation every 3–5 years, resulting in high-quality
surveillance data. For this study we only included hos-
pitals participating in both incidence surveillance and
prevalence surveys simultaneously, which resulted in
the most optimal link between the two.
There were also some limitations to this study.
Although strict protocols were implemented, routine
surveillance data is typically not collected for study
purposes, resulting in some important factors that
were not collected in the best way. In the incidence sur-
veillance, the type of surgery was collected, whereas
only the patient’s speciality was reported in the preva-
lence surveys. We have taken this into account as much
as possible by linking hospital data at the speciality
level, in order to make for the greatest comparability
between incidence and prevalence. Furthermore,
because dates of discharge were not available from
prevalence surveys, the estimates of LA, LN and INT
were derived from incidence surveillance. It is difﬁcult
to assess the impact this had on the results of Rhame
& Sudderth’s formula, especially for the analysis of
total SSI incidence where the SSIs that develop post-
discharge led to meaningless values for the duration
of infection (‘LN-INT’). However, when only SSIs dur-
ing the initial hospital stay were included, LA, LN and
INT most likely were lower than when prevalence data
would have been used, since prevalence surveys are
biased towards patients with longer lengths of stay.
How this impacted on the outcomes is highly depend-
ent on the ratios between the values. The used values
of LA, LN and INT might have inﬂuenced the per-
formance of the prediction models as well, but their
impact was likely to be limited. Finally, hospitals are
free to choose which types of surgery they want to
include in their incidence surveillance and may change
their selection annually. This means that the distribu-
tion of surgery types in the incidence surveillance is
not a reﬂection of the true distribution in the hospital,
and therefore the calculated SSI incidence at hospital
level is only based on a selection of the total number
of specialities in the hospital.
In conclusion, SSI incidence cannot be reliably pre-
dicted from SSI prevalence survey data using the cur-
rently available methods. This is caused by (i) the
design of the prevalence surveys, which give only a
snapshot of the current infection status of admitted
patients, (ii) the large number of SSIs that occur after
the initial hospitalization, and (iii) the infection duration
of SSIs which is difﬁcult to estimate and cannot be reli-
ably approximated by the ‘time from infection until dis-
charge’. We therefore conclude that prevalence surveys,
as currently implemented in The Netherlands, are not a
useful measure to estimate SSI incidence and that they
cannot replace SSI incidence surveillance in order to
reduce the workload and expenses for HAI surveillance.
Although these ﬁndings are likely to be universal, fur-
ther research should be performed to investigate
whether this also applies for other countries with similar
prevalence survey protocols [14, 15]. For infection pre-
vention purposes, both types of surveillance will remain
important and are in fact complementary. Prevalence
surveys can give a ﬁrst indication of the areas of interest
for infection control and are useful in visualizing trends,
while incidence surveillance is better equipped when
more in-depth information is needed. When choosing
a surveillance method, hospitals should always be
aware of the value of both surveillance systems and
keep in mind the goals they aim to achieve.
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